Secondary Prevention of Venous Thrombo Embolism (VTE).

Exclusion Criteria

• •Exclusion\_Criteria
• •Symptomatic DVT or PE at screening Interruption of anticoagulant therapy for 2 or more weeks during the 3-12 months of treatment for the prior VTE.
• •Patients who in the investigators judgement are perceived as having an excessive risk of bleeding Elevated Aspartate aminotransferase (AST) or Alanine tranminase (ALT) \> 2x ULN
• •Severe renal impairment (estimated creatinine clearance \<= 30 ml/min)